Search

Breast cancer is the most common cancer in women, and metastasis is the leading cause of death in breast cancer patients. Although chemoprevention is widely employed to treat breast cancer, anticancer drugs can cause significant adverse effects. Lysimachia christinae Hance (LH) is a traditional Chinese medicinal plant with diverse therapeutic effects. However, its potential anticancer activity has not been fully investigated in breast cancers to date. Using high‐performance liquid chromatography–mass spectrometry, we found that the main constituent of LH extract (LHE) was rutin. Our results indicated that LHE or rutin markedly decreased the proliferation and viability of estrogen receptor (ER)‐positive MCF‐7 and ER‐negative HCC38 human breast cancer cells. LHE treatment induced morphological changes in apoptotic nuclei using 4′,6‐diamidino‐2‐phenylindole (DAPI) staining. Annexin V–fluorescein isothiocyanate (FITC) propidium iodide (PI) staining assay revealed that apoptosis significantly increased in both breast cancer cell types after LHE treatment. Additionally, the expression of poly (ADP‐ribose) polymerase (PARP), Bcl‐2, and phospho‐Akt decreased, while that of cleaved PARP and p53 increased, in both cell types. Furthermore, LHE treatment inhibited epithelial–mesenchymal transition (EMT). LHE treatment significantly upregulated E‐cadherin level in MCF‐7 and HCC38 cells, while vimentin level was downregulated in HCC38 cells. In addition, transwell and wound‐healing assays revealed that LHE or rutin inhibited breast cancer cell migration. Overall, these findings demonstrate that LHE is a promising therapeutic agent that acts by promoting apoptosis and reducing cell proliferation, EMT, and cell migration in ER‐positive and ER‐negative breast cancer cells., Lysimachia christinae Hance extract (LHE) effectively showed anticancer effects by inhibiting cancer cell proliferation and inducing apoptosis in estrogen receptor (ER)‐positive MCF‐7 and ER‐negative HCC38 human breast cancer cells. Moreover, LHE negatively regulated epithelial–mesenchymal transition (EMT) and decreased breast cancer cell migration.

Recently reported genome-wide association studies have identified more than 20 common low-penetrance colorectal cancer (CRC) susceptibility loci. Recent studies have reported that copy number variations (CNVs) are considered important human genomic variants related to cancer, while the contribution of CNVs remains unclear. We performed array comparative genomic hybridization (aCGH) in 36 CRC patients and 47 controls. Using breakpoint PCR, we confirmed the breakpoint of the PKD1L2 deletion region. High frequency of PKD1L2 CNV was observed in CRC cases. We validated the association between PKD1L2 variation and CRC risk in 1,874 cases and 2,088 controls (OR=1.44, 95% CI=1.04-1.98, P=.028). Additionally, PKD1L2 CNV is associated with increased CRC risk in patients younger than 50 years (OR=2.14, 95% CI 1.39-3.30, P=5.8x10-4). In subgroup analysis according to body mass index (BMI), we found that the CN loss of PKD1L2 with BMI above or equal to 25 exhibited a significant increase in CRC risk (OR=2.29, 95% CI 1.29-4.05, P=.005). PKD1L2 CNV with BMI above or equal to 25 and age below 50 is associated with a remarkably increased risk of colorectal cancer (OR=5.24, 95% CI 2.36-11.64, P= 4.8x10-5). Moreover, we found that PKD1L2 variation in obese patients (BMI>=25) was associated with poor survival rate (P=.026). Our results suggest that the common PKD1L2 CNV is associated with CRC, and PKD1L2 CNV with high BMI and/or age below 50 exhibited a significant increased risk of CRC. In obese patients, PKD1L2 variation was associated with poor survival. This article is protected by copyright. All rights reserved.

The sustained release of growth factors following their implantation in vivo is essential for successful outcomes in bone tissue engineering. In this study, we evaluated the release kinetics and delivery efficacies of vascular endothelial growth factor (VEGF), a potent angiogenic growth factor, incorporated into calcium phosphate bone grafts (BGs). We evaluated the release profile of VEGF from BGs using a novel fluorescence-based retention assay, which revealed that VEGF loaded on BGs can be released in a sustained manner without an initial burst (near zero-order cumulative release) with a controlled release rate of 13.6% per week for up to 7 weeks. In contrast, an ELISA-based release assay showed VEGF to have an early burst-release profile for the first week. However, the biological activity of VEGF released from the BGs was preserved over the 7-week release period, which is consistent with the sustained-release profile observed in the fluorescence-based retention assay. Furthermore, the in vivo bone-forming action of the VEGF-loaded BGs was well demonstrated in a rat subcutaneous model. Taken together, the sustained release of VEGF loaded onto BGs was effective in stimulating proliferation, angiogenesis and osteogenesis, suggesting the ultimate value of VEGF-engineered BGs for bone tissue engineering.

BACKGROUND Soybeans have been widely used to alleviate climacteric symptoms. In this study, we investigated the oestrogenic activities of isoflavones extracted from Aspergillus oryzae-challenged germinated soybeans (AO-GS). Eight-week-old virgin Sprague–Dawley female rats were ovariectomised (OVX). The rats were orally administered 0.1 mg kg−1 17α-ethinyl oestradiol or three different doses of AO-GS (0.5, 1.0 2.0 g kg−1 day−1) in distilled water for 6 weeks, while control rats were administered vehicle alone. Uterine weights and levels of oestradiol and testosterone in serum were measured. In addition to serum parameters, bone parameters were also acquired by using micro-computed tomography scanning. RESULTS Treatments of OVX rats with AO-GS changed the secretory profile of serum oestradiol and testosterone. Serum oestradiol levels were significantly increased in OVX rats treated with and AO-GS (0.5, 1.0, 2.0 g kg−1 day−1), while serum testosterone levels were not significantly increased in OVX rats treated with 1.0 g kg−1 day−1 of AO-GS. Furthermore, AO-GS (2.0 g kg−1 day−1) significantly attenuated bone loss, increased trabecular bone volume fraction and trabecular thickness, and significantly decreased trabecular pattern factor. CONCLUSION AO-GS treatments caused moderate oestrogenic activity in OVX rats compared to those treated with oestradiol, suggesting the potential for the use of AO-GS in the treatment of menopausal symptoms and in osteoporosis caused by oestrogen deficiency. © 2015 Society of Chemical Industry

In Korea and China, the heartwood of Dalbergia odorifera T. Chen is an important traditional medicine used to treat blood disorders, ischemia, swelling, and epigastric pain. In this study, we investigated the inhibitory effects of latifolin, a major neoflavonoid component isolated from the MeOH extract of D. odorifera, on the inflammatory reaction of thioglycollate-elicited peritoneal macrophages exposed to lipopolysaccharide, with a particular focus on heme oxygenase-1 (HO-1) expression and nuclear factor-κB (NF-κB) signaling. Latifolin significantly inhibited the protein and mRNA expression of inducible nitric oxide synthase and COX-2, reduced NO, prostaglandins E2, tumor necrosis factor-α, and interleukin-1β production in primary murine peritoneal macrophages exposed to lipopolysaccharide. Latifolin also suppressed inhibitor κB-α levels, NF-κB nuclear translocation, and NF-κB DNA-binding activity. Furthermore, latifolin upregulated HO-1 expression via nuclear transcription factor-E2-related factor 2 (Nrf2) nuclear translocation. In addition, using inhibitor tin protoporphyrin IX (SnPP), an inhibitor of HO-1, it was verified that the inhibitory effects of latifolin on the proinflammatory mediators and NF-κB DNA-binding activity were associated with the HO-1 expression. These results suggested that the latifolin-mediated up-regulation of HO-1 expression played a critical role in anti-inflammatory effects in macrophages. This study therefore identified potent therapeutic effects of latifolin, which warrants further investigation as a potential treatment for inflammatory diseases.

Five known steroids, including three sulfated steroids, are isolated from the cold water starfish C.

Poly(amide imide)–epoxysilane (coupling agent) composites were reacted with silica, a condensation product of tetraethylorthosilicate (TEOS), by a sol–gel process and were then cast into films. After this procedure, the chemical characteristics and mechanical and thermal properties were measured. Fourier transform infrared showed that silica existed in the poly(amide imide) matrix. When a proper amount of silica was added to the poly(amide imide) matrix, the tensile strength, elongation, and toughness increased greatly. A poly(amide imide)/30 wt % epoxysilane composite with 20 wt % TEOS had the best mechanical properties. Thermogravimetric analysis under nitrogen and oxygen atmospheres indicated that the char contents increased with the amount of silica. The glass-transition temperatures of the poly(amide imide)–silica nanocomposites were observed around 170–180°C with differential scanning calorimetry. This approach may be a new method for the low-temperature thermal curing of poly(amide imide). © 2004 Wiley Periodicals, Inc. J Appl Polym Sci 94: 1780–1788, 2004

A series of poly(amide imide)–poly(dimethylsiloxane) (PDMS) nanocomposites were fabricated through the reaction of poly(amide imide), epoxysilane (coupling agent), and diethoxydimethylsilane (DEDMS) via a sol–gel process. Nanocomposite films were obtained through the hydrolysis and condensation of DEDMS in poly(amide imide) solutions. The existence of the condensation product of DEDMS in the poly(amide imide) matrix was confirmed with Fourier transform infrared (FTIR). The concentration of PDMS on the surface of the poly(amide imide) matrix was observed through a comparison of FTIR and attenuated total reflection spectra. The contact angle of the poly(amide imide)–PDMS composites increased more than 40° with respect to that of pure poly(amide imide). The alternating-current (ac) breakdown strength was obtained through the measurement of the ac breakdown voltage at the temperature of liquid nitrogen. As the PDMS concentration in poly(amide imide) increased, the characteristics of the insulation breakdown improved greatly. The best ac breakdown strength was observed in a poly(amide imide)–epoxysilane (30 wt %) nanocomposite with 30 wt % PDMS. The samples at the temperature of liquid nitrogen were brittle, as in a glassy state. © 2004 Wiley Periodicals, Inc. J Appl Polym Sci 93: 342–347, 2004

Polyamide/epoxysilane (coupling agent) composites were reacted with poly(dimethylsiloxane) (PDMS), a condensation product of diethoxydimethylsilane (DEDMS), by a sol–gel process. Polyamide–PDMS nanocomposites were obtained. The existence of the condensation product of DEDMS and the reaction between the epoxy group and the polyamide were confirmed with Fourier transform infrared, attenuated total reflection, and wide-scanning X-ray photoelectron spectroscopy. Atomic force microscopy and contact-angle measurements showed that the surface properties of polyamide were greatly improved by the addition of PDMS. The pyrolysis temperature of polyamide with PDMS was approximately 400°C, and the pyrolysis temperature was similar to that of pure polyamide. Also, the char contents increased with the addition of PDMS. The glass-transition temperature of polyamide with or without PDMS was approximately 140°C according to differential scanning calorimetry. © 2004 Wiley Periodicals, Inc. J Appl Polym Sci 94: 1947–1955, 2004

Polyamideimide (PAI)–epoxysilane (coupling agent) composites were reacted with oligomeric polydimethylsiloxane (PDMS), a condensation product of difunctional silane, by using the sol–gel process, and were then dried into films. After this procedure, the surface, mechanical, and thermal properties were measured. The study showed that PDMS existed in the PAI matrix by the use of FTIR. With respect to mechanical properties, the maximum elongation and toughness were increased in the PAI with silane groups, although the maximum tensile strength was slightly decreased. In this experiment, PAI–30 wt % epoxysilane composite had the best mechanical properties. The intensive dispersion of the silane groups on the surface of PAI was confirmed through XPS measurement. As a function of the siloxane contents, the TGA curve shows less thermal stability in terms of their initial weight loss. However, in an oxygen atmosphere at about 700°C, the series of PAI–siloxane composites indicated a significant increase in char concentration. In the end, PAI with a relevant amount of silane groups was improved in both toughness and surface properties. This experiment showed that PDMS added to PAI had better properties than those of classical materials. © 2003 Wiley Periodicals, Inc. J Appl Polym Sci 91: 1774–1783, 2004

isolation and structure elucidation of a new sesquiterpene, longanone A (I), showing nitrite inhibitory effects

Hericirine (I) inhibits significantly protein expression of iNOS and COX-2 and reduced NO, PEG2, TNF-α, IL-6, and IL-1β production in RAW264.7 cells exposed to LPS.

One new diketopiperazine alkaloid, deoxydihydroisoaustamide (I), and a new metabolite (II) are isolated together with the already known and structurally related deoxyisoaustamide.

Four new diterpene furanoids, hueafuranoids A—D, are isolated from the MeOH extract of Antarctic lichen Huea sp.